These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8818845)

  • 1. Concentrations of azithromycin in tonsilar and/or adenoid tissue from paediatric patients.
    Vaudaux BP; Cherpillod J; Dayer P
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():45-51. PubMed ID: 8818845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients.
    Blandizzi C; Malizia T; Batoni G; Ghelardi E; Baschiera F; Bruschini P; Senesi S; Campa M; Del Tacca M
    Antimicrob Agents Chemother; 2002 May; 46(5):1594-6. PubMed ID: 11959610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved tonsillar disposition of azithromycin following a 3-day oral treatment with 20 mg kg(-1) in paediatric patients.
    Baschiera F; Fornai M; Lazzeri G; Blandizzi C; Bruschini P; del Tacca M
    Pharmacol Res; 2002 Jul; 46(1):95-100. PubMed ID: 12208127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of cefprozil into tonsillar and adenoidal tissues.
    Shyu WC; Reilly J; Campbell DA; Wilber RB; Barbhaiya RH
    Antimicrob Agents Chemother; 1993 May; 37(5):1180-3. PubMed ID: 8517711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of azithromycin in human tonsillar tissue.
    Foulds G; Chan KH; Johnson JT; Shepard RM; Johnson RB
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):853-6. PubMed ID: 1662631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of azithromycin after single- and multiple-doses in children.
    Stevens RC; Reed MD; Shenep JL; Baker DK; Foulds G; Luke DR; Blumer JL; Rodman JH
    Pharmacotherapy; 1997; 17(5):874-80. PubMed ID: 9324176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin. A review of its use in paediatric infectious diseases.
    Langtry HD; Balfour JA
    Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability of 3-day, once-daily azithromycin suspension versus standard treatments for community-acquired paediatric infectious diseases.
    Treadway G; Reisman A
    Int J Antimicrob Agents; 2001 Nov; 18(5):427-31. PubMed ID: 11711256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paediatric safety of azithromycin: worldwide experience.
    Treadway G; Pontani D
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():143-9. PubMed ID: 8818855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of cefpodoxime in plasma, adenoid, and tonsillar tissue after repeated administrations of cefpodoxime proxetil in children.
    Bairamis TN; Nikolopoulos TP; Kafetzis DA; Begue P; Lenfant B; Kandiloros DC; Apostolopoulos NJ
    J Antimicrob Chemother; 1996 Apr; 37(4):821-4. PubMed ID: 8722549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of azithromycin into middle ear effusions in acute and secretory otitis media in children.
    Pukander J; Rautianen M
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():53-61. PubMed ID: 8818846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open, multicentre, comparative study of the efficacy and safety of azithromycin and co-amoxiclav in the treatment of upper and lower respiratory tract infections in children. The Paediatric Azithromycin Study Group.
    Lauvau DV; Verbist L
    J Int Med Res; 1997; 25(5):285-95. PubMed ID: 9364291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen.
    Liu P; Allaudeen H; Chandra R; Phillips K; Jungnik A; Breen JD; Sharma A
    Antimicrob Agents Chemother; 2007 Jan; 51(1):103-9. PubMed ID: 17060516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of intravenously administered azithromycin in pediatric patients.
    Jacobs RF; Maples HD; Aranda JV; Espinoza GM; Knirsch C; Chandra R; Fisher JM; Kearns GL
    Pediatr Infect Dis J; 2005 Jan; 24(1):34-9. PubMed ID: 15665708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin.
    Lucchi M; Damle B; Fang A; de Caprariis PJ; Mussi A; Sanchez SP; Pasqualetti G; Del Tacca M
    J Antimicrob Chemother; 2008 Apr; 61(4):884-91. PubMed ID: 18252692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodontal tissue disposition of azithromycin.
    Malizia T; Tejada MR; Ghelardi E; Senesi S; Gabriele M; Giuca MR; Blandizzi C; Danesi R; Campa M; Del Tacca M
    J Periodontol; 1997 Dec; 68(12):1206-9. PubMed ID: 9444596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic and clinical studies with azithromycin (fine granule) in the pediatric field. Pediatric Study Group of Azithromycin].
    Tajima T; Kobayashi M; Terashima I; Meguro H; Sunakawa K; Yokota T; Akita H; Iwata S; Takeuchi Y; Fujii R
    Jpn J Antibiot; 1995 Sep; 48(9):1051-73. PubMed ID: 7474329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers.
    Amsden GW; Gray CL
    J Antimicrob Chemother; 2001 Jan; 47(1):61-6. PubMed ID: 11152432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of dose regimens of azithromycin .
    Foulds G; Johnson RB
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():39-50. PubMed ID: 8396095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered dipeptidyl peptidase IV and prolyl endopeptidase activities in chronic tonsillitis, tonsillar hyperplasia and adenoid hyperplasia.
    Larrinaga G; Pérez I; Sanz B; Zarrazquin I; Casis L; Anta JA; Martínez A; Santaolalla F
    Int J Pediatr Otorhinolaryngol; 2011 Mar; 75(3):347-50. PubMed ID: 21185091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.